Efficacy, Safety and Tolerability of Guideline-Recommended ARVs from Pediatric Clinical Trials: A Systematic Review

International Workshop on HIV Pediatrics 2021

Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non-Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial

International Workshop on HIV Pediatrics 2021

B/F/Taf in Virologically Suppressed Adolescents and Children: Two-Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers

International Workshop on HIV Pediatrics 2021

Long-term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen in in Children and Adolescents Living with HIV

International Workshop on HIV Pediatrics 2021

Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 kg: Preliminary Results from IMPAACT 2019

International Workshop on HIV Pediatrics 2021

Pharmacokinetics, Safety and Acceptability of a Single Dose of Abacavir/Lamivudine/Lopinavir/Ritonavir (4-In-1) Fixed-Dose Granule Formulation In Neonates: PETITE Study

International Workshop on HIV Pediatrics 2021

Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa

International Workshop on HIV Pediatrics 2021

Weight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY Trial

International Workshop on HIV Pediatrics 2021

Dolutegravir and Weight Gain to Adolescents Living with HIV at Baylor Mwanza-Tanzania

International Workshop on HIV Pediatrics 2021

Longitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South Africa

International Workshop on HIV Pediatrics 2021

Hypertensive Disorders in Pregnancy and HIV: A Province-Wide Cohort Analysis During 2018 and 2019 in the Western Cape, South Africa

International Workshop on HIV Pediatrics 2021

Bone Mineral Density/Content of Postpartum Mothers Taking Treatment Including DTG Vs EFV, TDF Vs TAF in Pregnancy and Their Infants: Randomized IMPAACT 2010 Trial

International Workshop on HIV Pediatrics 2021

Impact of the COVID-19 pandemic on perinatal HIV prevention In Canada: Canadian Perinatal HIV Surveillance Program

International Workshop on HIV Pediatrics 2021

A Comparative Multi-Country Analysis of the Impact of COVID-19 on HIV Services for Pregnant and Breastfeeding Women and Their Infants

International Workshop on HIV Pediatrics 2021

The Impact of COVID-19 on HIV Services for Children Living with HIV Across 14 Countries

International Workshop on HIV Pediatrics 2021

Knowledge and Perceptions of Covid-19 Among Young People Living With HIV in Malawi and the Impact of the Pandemic on Their Health and Wellbeing

International Workshop on HIV Pediatrics 2021

More Frequent Viral Load Testing, With Point-Of-Care Tests Has No Impact on Viral Suppression in Postpartum HIV-Positive Women in a Randomized Controlled Trial in 2 Clinics in Johannesburg, South Africa

International Workshop on HIV Pediatrics 2021

Usability and Feasibility of an HIV POC Viral Load to Identify Infants at High Risk of MTCT at Birth in Primary Healthcare Clinics in Mozambique

International Workshop on HIV Pediatrics 2021

Key Clinical and Programmatic Outcomes of HIV-Exposed Infants in the International Epidemiology Databases to Evaluate AIDS Consortium

International Workshop on HIV Pediatrics 2021

Determinants of HIV-Free Survival in the Era of Lifelong Universal Antiretroviral Therapy (ART): Pooled Analysis of PEAWIL and IMPROVE Studies, Lesotho

International Workshop on HIV Pediatrics 2021

Increased Infectious-Cause Hospitalization Among Infants Who Are HIV-Exposed Uninfected Compared to HIV-Unexposed

International Workshop on HIV Pediatrics 2021

Growth of Children HIV-Exposed and Uninfected in The Context of Lifelong Maternal Antiretroviral Therapy in Malawi

International Workshop on HIV Pediatrics 2021

There is No Substitute for Hard Work(Ing Dolutegravir): Outcomes of Single Drug Substitutions Among CALHIV Shifted to a Dolutegravir Antiretroviral Regimen in Mbeya and Mwanza, Tanzania

International Workshop on HIV Pediatrics 2021

Pediatric ARV optimization in a real-world setting: Dolutegravir transition in Mozambique

International Workshop on HIV Pediatrics 2021